Group One Trading’s Agile Therapeutics AGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-10
| Closed | -$20 | – | 8308 |
|
|
2023
Q4 | $20 | Hold |
10
| – | – | ﹤0.01% | 7248 |
|
|
2023
Q3 | $24 | Hold |
10
| – | – | ﹤0.01% | 7520 |
|
|
2023
Q2 | $30 | Sell |
10
-2
| -17% | -$11 | ﹤0.01% | 7548 |
|
|
2023
Q1 | $132 | Hold |
12
| – | – | ﹤0.01% | 7021 |
|
|
2022
Q4 | $134 | Sell |
12
-8
| -40% | -$93 | ﹤0.01% | 7060 |
|
|
2022
Q3 | $0 | Sell |
20
-1
| -5% | -$25 | ﹤0.01% | 8533 |
|
|
2022
Q2 | $1K | Hold |
21
| – | – | ﹤0.01% | 7679 |
|
|
2022
Q1 | $9K | Buy |
21
+5
| +31% | +$3.19K | ﹤0.01% | 7224 |
|
|
2021
Q4 | $15K | Sell |
16
-7
| -30% | -$9.87K | ﹤0.01% | 7161 |
|
|
2021
Q3 | $43K | Buy |
23
+5
| +28% | +$11.3K | ﹤0.01% | 6670 |
|
|
2021
Q2 | $48K | Buy |
18
+11
| +157% | +$36.3K | ﹤0.01% | 6624 |
|
|
2021
Q1 | $27K | Sell |
7
-36
| -84% | -$195K | ﹤0.01% | 6624 |
|
|
2020
Q4 | $246K | Hold |
43
| – | – | ﹤0.01% | 3908 |
|
|
2020
Q3 | $260K | Buy |
43
+42
| +4,200% | +$241K | ﹤0.01% | 3440 |
|
|
2020
Q2 | $7K | Sell |
1
-44
| -98% | -$229K | ﹤0.01% | 5285 |
|
|
2020
Q1 | $169K | Buy |
45
+20
| +80% | +$115K | ﹤0.01% | 2891 |
|
|
2019
Q4 | $124K | Buy |
25
+11
| +79% | +$38.4K | ﹤0.01% | 3502 |
|
|
2019
Q3 | $33K | Buy |
14
+13
| +1,300% | +$32K | ﹤0.01% | 4175 |
|
|
2019
Q2 | $2K | Hold |
1
| – | – | ﹤0.01% | 4783 |
|
|
2019
Q1 | $2K | Hold |
1
| – | – | ﹤0.01% | 4618 |
|
|
2018
Q4 | $1K | Sell |
1
-1
| -50% | -$1.53K | ﹤0.01% | 4764 |
|
|
2018
Q3 | $1K | Sell |
2
-2
| -50% | -$1.46K | ﹤0.01% | 5096 |
|
|
2018
Q2 | $4K | Buy |
4
+3
| +300% | +$10.5K | ﹤0.01% | 4866 |
|
|
2018
Q1 | $5K | Hold |
1
| – | – | ﹤0.01% | 4521 |
|
|
2017
Q4 | $5K | Buy |
+1
| New | +$9.31K | ﹤0.01% | 4580 |
|
Other funds holding AGRX
Group One Trading's AGRX Position: Q1 2024 in Review
Group One Trading sold out of Agile Therapeutics (AGRX) in Q1 2024, closing a stake of 10 shares — an estimated $20 sold.
Group One Trading first reported a position in AGRX in Q4 2017 and held it in 25 quarters. The position peaked at $260K in Q3 2020. 1 fund tracked by Wall St. Rank holds AGRX as of Q1 2024.
- Group One Trading reported no remaining Agile Therapeutics position as of Q1 2024 after selling out during the quarter.
- Group One Trading sold 10 Agile Therapeutics shares in Q1 2024, an estimated $20.
- Group One Trading first reported a position in Agile Therapeutics in Q4 2017 and held it in 25 quarters.
- Group One Trading's Agile Therapeutics position peaked at $260K in Q3 2020.
- 1 fund tracked by Wall St. Rank held Agile Therapeutics as of Q1 2024.
Based on Group One Trading's 13F filing for Q1 2024, filed 10 May 2024.